June 15, 2026 C-Path Reaffirms Commitment to Advancing Regulatory Science for Disease-Modifying Therapies in Type 1 Diabetes TUCSON, Ariz., June 15, 2026 — Critical Path Institute® (C-Path), through its Type 1 Diabetes Consortium, today...
June 11, 2026 C-Path Appoints Biotech Executive and Investor Dr. Milad Alucozai to Board of Directors TUCSON, Ariz., June 11, 2026 — Critical Path Institute® (C-Path) today announced the appointment of Milad Alucozai...
June 10, 2026 C-Path Appoints Biotechnology Leader and Veteran Life-Science Attorney Yalonda Howze to Board of Directors TUCSON, Ariz., June 10, 2026 — Critical Path Institute® (C-Path) today announced the appointment of Yalonda Howze...
June 9, 2026 Critical Path Institute to Convene Drug Development Leaders at 2026 Global Impact Conference TUCSON, Ariz., June 9, 2026 — Critical Path Institute® (C-Path) will host its 2026 Global Impact Conference (CGIC) this...
May 20, 2026 Critical Path Institute Awards $249,719 Grant to Odylia Therapeutics to Advance Gene Therapy for USH1C-Associated Vision Loss TUCSON, Ariz., May 20, 2026 — Critical Path Institute® (C-Path) today announced the award of a $249,719 research grant...
May 19, 2026 Critical Path Institute Launches New Approach Methodologies Developer Coalition to Advance Human-Relevant Tools for Drug Development TUCSON, Ariz., and AMSTERDAM, May 19, 2026 — Critical Path Institute® (C-Path) today announced the launch of the New...
April 28, 2026 Critical Path Institute Awards $456,000 Grant to Advance Next-Generation Therapy for Rare Glycolipid Storage Disorders TUCSON, Ariz., April 28, 2026 — Critical Path Institute® (C-Path) today announced a $456,000 grant to James Shayman...
April 22, 2026 AIRNA Joins C-Path’s Alpha-1 Antitrypsin Deficiency Consortium to Advance Innovative AATD Treatments TUCSON, Ariz., April 22, 2026 — Critical Path Institute’s® (C-Path) Critical Path for Alpha-1 Antitrypsin...
April 8, 2026 C-Path’s Translational Therapeutics Accelerator Awards $501,000 Grant to Advance Novel Treatment for Cryptosporidiosis in Children TUCSON, Ariz., April 8, 2026 — Critical Path Institute’s® (C-Path) Translational Therapeutics Accelerator has awarded...
March 26, 2026 Critical Path Institute Launches ‘One to Millions’ to Reshape the Future of Individualized Medicine at Global Scale C-Path today announced the launch of One to Millions, a global, multi-stakeholder public-private initiative...